The Gritstone Bio Public Offering: The Road to Stock Price Volatility

Avatar photo
GRTS Stock - Why Is Gritstone Bio (GRTS) Stock Down 44% Today?

Source: Gorodenkoff / Shutterstock.com

Gritstone Bio (NASDAQ:GRTS) issued a public offering, a strategic move that has set the stage for a tumultuous day in the stock market. The company put up 8,333,333 shares of GRTS stock for sale at a price of $1.50 per share, accompanied by warrants for an additional 8,333,333 shares. Investors also have the option to purchase pre-funded warrants in lieu of stock, which equates to 13,334,222 shares priced at $1.65 each.

The anticipated gross proceeds for Gritstone Bio from this offering amount to $32.5 million. While the company has not explicitly outlined its utilization plans for these funds, it has appointed TD Cowen and Evercore ISI as the joint book-running managers for the transaction.

Implications on GRTS Stock

Public offerings are known to augment the existing pool of shares in circulation, inevitably leading to a reduction in the ownership percentages of current shareholders. The plummeting trajectory of GRTS stock can be attributed to this phenomenon among others.

Furthermore, the pricing of shares in the offering is notably lower than the preceding day’s closing price of $2.35 per share for GRTS stock. This considerable discount naturally triggered a devaluation of GRTS shares in tandem with the public offering announcement.

As of the current trading session, GRTS stock has taken a 43.8% dive, with trading volume clocking in at 1.9 million shares, a slight dip from the average daily volume of approximately 2.2 million shares.

Curious about more stock market tidbits?

Explore the hottest stock market updates for today, including insights on Acorda Therapeutics (NASDAQ:ACOR), Kidpik (NASDAQ:PIK), and XTI Aerospace (NASDAQ:XTIA) stocks. Dive into the details right below!

Further Stock Market Revelations for Tuesday

As of the publication date, William White retains no direct or indirect holdings in the securities discussed in this article. The opinions articulated are personal and comply with the InvestorPlace.com Editorial Guidelines.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now